Grifols SA ADR (GRFS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $5.91B
Last updated: Nov 17, 2026 at 4:25 PM ET
Grifols SA ADR (GRFS) Statistics
Grifols SA ADR (GRFS) has a market cap of $5.91B. Its trailing P/E is 9.8x.
Total Valuation
| Market Cap | $5.91B |
|---|---|
| Latest price (Nov 17, 2026) | $8.63 |
Key Dates
The next ex-dividend date is Dec 3, 2026.
| Last Earnings Date | Nov 2, 2026 |
|---|---|
| Next Ex-Dividend Date | Dec 3, 2026 |
| Next Payment Date | Jan 11, 2027 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.7x and 0.9x.
| P/E Ratio | 9.8x |
|---|---|
| P/S Ratio | 0.7x |
| P/B Ratio | 0.9x |
| P/FCF Ratio | 6.8x |
| PEG Ratio | 0.5 |
Enterprise Valuation
Counting debt and cash, the company is valued at 7.5x EBITDA and 18.3x free cash flow.
| EV / EBITDA | 7.5x |
|---|---|
| EV / FCF | 18.3x |
Price Statistics
The stock is up 0.39% over 52 weeks and trades 10.93% above its 50-day average.
| Beta (1Y) | 0.81 |
|---|---|
| 52-Week Change | +0.39% |
| 1-Month Change | +12.96% |
| 3-Month Change | +4.61% |
| 6-Month Change | +11.53% |
| 5-Year Change | -38.22% |
| 10-Year Change | -43.32% |
| Total Return (1Y) | +1.49% |
| Total Return (3Y CAGR) | -2.16% |
| Total Return (5Y CAGR) | -5.92% |
| Return vs SPY (1Y) | -9.89% |
| Max Drawdown (1Y) | -27.16% |
| Max Drawdown (3Y) | -52.68% |
| Sharpe Ratio (1Y) | 0.05 |
| Correlation with SPY (1Y) | 0.35 |
| 50-Day Average | $7.78 |
| 200-Day Average | $7.92 |
| 52-Week Range | $6.87 to $9.64 |
| RSI (14 Days) | 64.1 |
| Average Volume (20 Days) | 761.36K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.33x current liabilities, and total debt is 1.60x shareholder equity.
| Current Ratio | 2.33x |
|---|---|
| Quick Ratio | 0.82x |
| Debt / Equity | 1.60x |
| Debt / EBITDA | 4.96x |
| Interest Coverage | 2.58x |
Returns and Efficiency
Return on invested capital is 7.58% over the last 12 months, against a 5-year average of 4.29%.
| Return on Equity (ROE) | 9.00% |
|---|---|
| Return on Assets (ROA) | 2.57% |
| Return on Invested Capital (ROIC) | 7.58% |
| Return on Capital Employed (ROCE) | 7.69% |
| ROE (5Y Average) | 3.50% |
| ROA (5Y Average) | 0.95% |
| ROIC (5Y Average) | 4.29% |
| Asset Turnover | 0.38x |
| Inventory Turnover | 1.39x |
| Receivables Turnover | 6.78x |
| Cash Conversion Cycle | 279 days |
Taxes
Income tax took 18.86% of pretax income over the last 12 months.
| Income Tax (TTM) | EUR 140.86M |
|---|---|
| Effective Tax Rate | 18.86% |
Scores
GRFS has an Altman Z-Score of 1.07, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.07 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of EUR 7.61B over the last 12 months is up 1.16% from the 12 months before.
| Revenue | EUR 7.61B |
|---|---|
| Revenue Growth (YoY) | +1.16% |
| Gross Profit | EUR 2.83B |
| Operating Income | EUR 1.28B |
| Pretax Income | EUR 746.90M |
| Net Income | EUR 514.53M |
| EBITDA | EUR 1.84B |
| EBIT | EUR 1.38B |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 28.55% of the EUR 20.28B in total assets.
| Working Capital | EUR 3.05B |
|---|---|
| Shareholder Equity | EUR 5.79B |
| Tangible Book Value | EUR -5.01B |
| Total Assets | EUR 20.28B |
| Total Liabilities | EUR 12.04B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After EUR 372.00M of capital spending, operating cash flow left EUR 746.67M of free cash flow.
| Operating Cash Flow | EUR 1.12B |
|---|---|
| Capital Expenditures | EUR 372.00M |
| Free Cash Flow | EUR 746.67M |
| Depreciation and Amortization | EUR 455.08M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 16.87%, against a 5-year average of 13.96%.
| Gross Margin | 37.26% |
|---|---|
| Operating Margin | 16.87% |
| Pretax Margin | 9.82% |
| Net Margin | 6.77% |
| EBITDA Margin | 24.16% |
| EBIT Margin | 18.18% |
| FCF Margin | 9.82% |
| Gross Margin (5Y Average) | 37.68% |
| Operating Margin (5Y Average) | 13.96% |
| Net Margin (5Y Average) | 3.01% |
Growth
Revenue grew 6.02% a year over 3 years.
| Revenue Growth (3Y CAGR) | +6.02% |
|---|---|
| Revenue Growth (5Y CAGR) | +6.24% |
| FCF Growth (5Y CAGR) | +0.09% |
| Operating Income Growth (3Y CAGR) | +14.91% |
Dividends and Yields
GRFS pays out 4.99% of earnings as dividends.
| Dividend Per Share (Annual) | $0.09 |
|---|---|
| Dividend Yield | 1.10% |
| Payout Ratio | 4.99% |
| Earnings Yield | 10.20% |
| FCF Yield | 14.65% |
Stock Splits
The last split was a 2-for-1 forward split on Jan 4, 2016.
| Last Split Date | Jan 4, 2016 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 7 similar companies, GRFS has the 7th highest P/E.
P/E RatioPeer median 21.3x
P/S RatioPeer median 3.6x
ROICPeer median 5.19%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +4.16%
Dividend YieldPeer median 0.00%
| P/E Ratio | 9.8x vs 21.3x median |
|---|---|
| P/S Ratio | 0.7x vs 3.6x median |
| ROIC | 7.58% vs 5.19% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +1.16% vs +4.16% median |
| Dividend Yield | 1.09% vs 0.00% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About GRFS
What is GRFS's market cap?
Grifols SA ADR has a market cap of $5.91B.
What is GRFS's P/E ratio?
Grifols SA ADR has a trailing P/E ratio of 9.8x.
How many shares of GRFS are outstanding?
Grifols SA ADR has 680.58M shares outstanding. The count is up 0.01% from a year earlier.
Does GRFS pay a dividend?
Yes. Grifols SA ADR pays $0.09 a share a year, a dividend yield of 1.10%.
GRFS pages: Overview, Dividends, Charting, Financials, Statistics, Valuation, Competitors, Government Contracts